We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

99 hedge funds and large institutions have $690M invested in Heron Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more call options, than puts

Call options by funds: $21.1M | Put options by funds: $8.42M

134.39% more ownership

Funds ownership: 0% → 134.39% (+134%)

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

13% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 30

9% more funds holding

Funds holding: 91 → 99 (+8)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

22% less capital invested

Capital invested by funds: $881M → $690M (-$191M)

Holders
99
Holders Change
+8
Holders Change %
+8.79%
% of All Funds
2.48%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
18
Increased
34
Reduced
30
Closed
10
Calls
$21.1M
Puts
$8.42M
Net Calls
+$12.7M
Net Calls Change
+$7.51M

Top Buyers

1
BC
Broadfin Capital
New York
+$16.5M
2
HCMT
Highland Capital Management (Texas)
Texas
+$14.3M
3
JHIU
Janus Henderson Investors US
Colorado
+$8.5M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$5.13M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$5.04M

Top Sellers

1
Invesco
Invesco
Georgia
-$34.3M
2
PHS
PFM Health Sciences
California
-$10.3M
3
BBA
Baker Bros. Advisors
New York
-$7.43M
4
RI
RTW Investments
New York
-$6.66M
5
Asset Management One
Asset Management One
Japan
-$4.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
IF
76
Ironwood Financial
Arizona
$102K +$122K +7,800 New
QT
77
Quantbot Technologies
New York
$90K +$108K +6,891 New
Fifth Third Bancorp
78
Fifth Third Bancorp
Ohio
$40K -$31K -1,974 -39%
Canada Life
79
Canada Life
Manitoba, Canada
$39K – – –
BlackRock
80
BlackRock
New York
$37K -$12.4K -789 -22%
SEI Investments
81
SEI Investments
Pennsylvania
$28K +$94 +6 +0.3%
Simplex Trading
82
Simplex Trading
Illinois
$27K +$32.4K +2,067 New
Zurich Cantonal Bank
83
Zurich Cantonal Bank
Switzerland
$21K – – –
MFS
84
MSI Financial Services
Massachusetts
$20K – – –
PNC Financial Services Group
85
PNC Financial Services Group
Pennsylvania
$20K +$11.3K +723 +93%
GWM
86
Geneos Wealth Management
Colorado
$8K -$392 -25 -4%
Parallax Volatility Advisers
87
Parallax Volatility Advisers
California
$8K – – –
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
$7.26K -$25.2K -1,609 -74%
LTFS
89
Ladenburg Thalmann Financial Services
Florida
$7K -$7.84K -500 -50%
MAM
90
Meeder Asset Management
Ohio
$5K +$6.26K +399 New
NFG
91
Next Financial Group
Texas
$3K +$3.14K +200 New
PA
92
Parallel Advisors
California
$3K +$3.92K +250 New
TRCT
93
Tower Research Capital (TRC)
New York
$1K -$4.11K -262 -77%
FANJ
94
Financial Architects (New Jersey)
New Jersey
$1K -$314 -20 -33%
AG
95
Advisor Group
Arizona
$1K -$298 -19 -33%
US Bancorp
96
US Bancorp
Minnesota
$1K +$643 +41 New
SFS
97
Sowell Financial Services
Arkansas
$1K +$785 +50 New
WEC
98
Winslow Evans & Crocker
Massachusetts
$14 – – –
RI
99
RTW Investments
New York
– -$6.66M -386,787 Closed
Asset Management One
100
Asset Management One
Japan
– -$4.69M -274,368 Closed
1 2 3
4
5

HRTX Hedge Fund Activity: Q4 2016 in Review

99 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2016, worth a combined $690M — down 22% from $881M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HRTX positions and 10 closed out — a net gain of 8 holders — while 34 added to existing stakes and 30 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $16.5M. The largest seller was Invesco, cutting an estimated $34.3M.

  • 99 institutional investors held Heron Therapeutics (HRTX) as of Q4 2016, up from 91 in Q3 2016.
  • Funds reported $690M of Heron Therapeutics stock for Q4 2016, down 22% quarter-over-quarter.
  • 18 funds opened new Heron Therapeutics positions in Q4 2016 and 10 closed out, a net change of +8 holders.
  • The largest Heron Therapeutics buyer in Q4 2016 was Broadfin Capital, an estimated $16.5M added.
  • The largest Heron Therapeutics seller in Q4 2016 was Invesco, an estimated $34.3M sold.

Based on aggregated 13F filings for Q4 2016.